Back to search

SM16, an Orally Active TGF-β Type I Receptor Inhibitor Prevents Myofibroblast Induction and Vascular Fibrosis in the Rat Carotid Injury Model

Data up to Jan 2025

Published2008
Citations78
References46

Total Citations Per Year

Abstract

References (46)

SPECIFICITY AND VERSATILITY IN TGF-β SIGNALING THROUGH SMADS

2005 • 1,804 citations

Production of transforming growth factor beta 1 during repair of arterial injury.

1991 • 539 citations

Contribution of Adventitial Fibroblasts to Neointima Formation and Vascular Remodeling

2001 • 488 citations

TGF-β signaling in vascular fibrosis

2007 • 469 citations

Crystal Structure of the Cytoplasmic Domain of the Type I TGF β Receptor in Complex with FKBP12

1999 • 433 citations

Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin.

1994 • 377 citations

Antibodies against transforming growth factor-beta 1 suppress intimal hyperplasia in a rat model.

1994 • 303 citations

Transforming Growth Factor-βs and Vascular Disorders

2006 • 249 citations

Progressive Transforming Growth Factor β1–induced Lung Fibrosis Is Blocked by an Orally Active ALK5 Kinase Inhibitor

2004 • 246 citations

Roles of activin in tissue repair, fibrosis, and inflammatory disease

2006 • 207 citations

Soluble Transforming Growth Factor-β Type II Receptor Inhibits Negative Remodeling, Fibroblast Transdifferentiation, and Intimal Lesion Formation But Not Endothelial Growth

1999 • 197 citations

IN-1130, a novel transforming growth factor-β type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy

2006 • 191 citations

Inhibition of Gene Markers of Fibrosis with a Novel Inhibitor of Transforming Growth Factor-β Type I Receptor Kinase in Puromycin-Induced Nephritis

2005 • 183 citations

Successful shape-Based virtual screening: The discovery of a potent inhibitor of the type I TGFβ receptor kinase (TβRI)

2003 • 161 citations

Inhibition of TGF‐β signaling by an ALK5 inhibitor protects rats from dimethylnitrosamine‐induced liver fibrosis

2005 • 156 citations

SOME NEW STAINING METHODS OF WIDE APPLICABILITY.

1908 • 136 citations

Activin A Is a Potent Activator of Renal Interstitial Fibroblasts

2004 • 132 citations

Attenuation of Bleomycin-induced Pulmonary Fibrosis by Follistatin

2005 • 104 citations

Discovery of 4-{4-[3-(Pyridin-2-yl)-1H-pyrazol-4-yl]pyridin-2-yl}-N-(tetrahydro-2H- pyran-4-yl)benzamide (GW788388): A Potent, Selective, and Orally Active Transforming Growth Factor-β Type I Receptor Inhibitor

2006 • 100 citations

Understanding the role of transforming growth factor-β1 in intimal thickening after vascular injury

2007 • 100 citations

Transforming Growth Factor-Beta-Dependent Events in Vascular Remodeling following Arterial Injury

2003 • 96 citations

Expression of activin A is increased in cirrhotic and fibrotic rat livers

1998 • 92 citations

Role of p38 Mitogen-Activated Protein Kinase in Neointimal Hyperplasia After Vascular Injury

2000 • 92 citations

Inhibition of activin receptor-like kinase 5 attenuates Bleomycin-induced pulmonary fibrosis

2006 • 91 citations

Intracellular TGF-β Receptor Blockade Abrogates Smad-Dependent Fibroblast Activation In Vitro and In Vivo

2006 • 88 citations

The Dependence of Transforming Growth Factor-β-Induced Collagen Production on Autocrine Factor Activin A in Hepatic Stellate Cells

2004 • 80 citations

Expression of immunoreactive activin A protein in remodeling lesions associated with interstitial pulmonary fibrosis.

1996 • 78 citations

Transforming Growth Factor-β Receptor Type 1 (TGFβRI) Kinase Activity but Not p38 Activation Is Required for TGFβRI-Induced Myofibroblast Differentiation and Profibrotic Gene Expression

2006 • 74 citations

Targeted Disruption of TGF-β–Smad3 Signaling Leads to Enhanced Neointimal Hyperplasia With Diminished Matrix Deposition in Response to Vascular Injury

2005 • 73 citations

Mini ReviewActivin Receptor Signaling

2004 • 65 citations

Effect of Transforming Growth Factor-β Receptor I Kinase Inhibitor 2,4-Disubstituted Pteridine (SD-208) in Chronic Allergic Airway Inflammation and Remodeling

2006 • 62 citations

Stimulation of activin A expression in rat aortic smooth muscle cells by thrombin and angiotensin II correlates with neointimal formation in vivo.

1997 • 61 citations

Smad7 Gene Transfer Attenuates Adventitial Cell Migration and Vascular Remodeling After Balloon Injury

2005 • 57 citations

Local Expression of Bovine Decorin by Cell-Mediated Gene Transfer Reduces Neointimal Formation After Balloon Injury in Rats

2000 • 56 citations

Differential effect of activin A and BMP-7 on myofibroblast differentiation and the role of the Smad signaling pathway.

2002 • 52 citations

Sustained Activation of p38 Mitogen-Activated Protein Kinase Contributes to the Vascular Response to Injury

2002 • 50 citations

TGF-β1 Expression in Renal Allograft Rejection and Cyclosporine A Toxicity

2005 • 43 citations

Antisense to transforming growth factor-β1 messenger RNA reduces vein graft intimal hyperplasia and monocyte chemotactic protein 1

2005 • 42 citations

TGFβ is active, and correlates with activators of TGFβ, following porcine coronary angioplasty

2001 • 37 citations

Novel cardiovascular actions of the activins

1999 • 34 citations

Glomerular activin A overexpression is linked to fibrosis in anti-Thy1 glomerulonephritis

2005 • 33 citations

Effect of TGF-β<sub>1</sub> Antisense S-Oligonucleotide on Synthesis and Accumulation of Matrix Proteoglycans in Balloon Catheter-Injured Neointima of Rabbit Carotid Arteries

2000 • 33 citations

Potential contribution of bone marrow-derived precursors to vascular repair and lesion formation: lessons from animal models of vascular diseases

2007 • 28 citations

Chimeric DNA–RNA hammerhead ribozyme targeting transforming growth factor-β1 mRNA inhibits neointima formation in rat carotid artery after balloon injury

2003 • 28 citations

Contribution of Mesenchymal Progenitor Cells to Tissue Repair in Rat Cardiac Allografts Undergoing Chronic Rejection

2005 • 22 citations

The Use of Virtual Screening in ALK5 Kinase Inhibitor Discovery and Validation of Orally Active ALK5 Kinase Inhibitors in Oncology

2008 • 8 citations

Cited By (0)

No citing papers found in database

SM16, an Orally Active TGF-β Type I Receptor Inhibitor Prevents Myofibroblast Induction… (2008) – Arteriosclerosis Thrombosis and Vascular Biology | Metascience Observatory Explorer